These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 525984)

  • 1. Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.
    Wise R; Cadge B; Gillett AP; Bhamjee A; Livingston R; Welling PG; Thornhill DP
    Antimicrob Agents Chemother; 1979 May; 15(5):670-3. PubMed ID: 525984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of a new ureidopenicillin: Bay K 49999.
    Lode H; Tomas W; Koeppe P; Wagner J
    Chemotherapy; 1980; 26(2):81-90. PubMed ID: 7363710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of furazlocillin in healthy humans.
    Hinderling PH; Gundert-Remy U; Förster D; Gau W
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):5-30. PubMed ID: 6875810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue penetration of temocillin.
    Lockley MR; Brown RM; Wise R
    Drugs; 1985; 29 Suppl 5():106-8. PubMed ID: 4029011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S184-90. PubMed ID: 7152688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM; Francke EF; Neu HC
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid.
    Walstad RA; Hellum KB; Thurmann-Nielsen E; Dale LG
    J Antimicrob Chemother; 1986 May; 17 Suppl C():71-80. PubMed ID: 3722049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
    Wise R; Gillett AP; Cadge B; Durham SR; Baker S
    J Infect Dis; 1980 Jul; 142(1):77-82. PubMed ID: 7400630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of azlocillin in neonates.
    Sitka U; Weingärtner L; Patsch R; Richter I
    Chemotherapy; 1980; 26(3):171-6. PubMed ID: 7363714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
    Gootz TD; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.